Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 1,044 | 648 | 1,146 | 1,797 | 905 |
| Cost of Goods | 372 | 331 | 273 | 232 | 297 |
| Gross Profit | 672 | 316 | 873 | 1,565 | 608 |
| Operating Expenses | 3,184 | 3,822 | 3,988 | 4,400 | 4,327 |
| Operating Income | -2,140 | -3,175 | -2,843 | -2,602 | -3,422 |
| Other Income | -6 | -9 | -12 | -9 | -7 |
| Pre-tax Income | -2,146 | -3,184 | -2,855 | -2,611 | -3,429 |
| Net Income Continuous | -2,146 | -3,184 | -2,855 | -2,611 | -3,429 |
| Net Income | $-2,146 | $-3,184 | $-2,855 | $-2,611 | $-3,429 |
| EPS Basic Total Ops | -56.00 | -96.00 | -80.00 | -80.00 | -104.00 |
| EPS Basic Continuous Ops | -57.02 | -92.03 | -81.95 | -79.19 | -104.10 |
| EPS Diluted Total Ops | -56.00 | -96.00 | -80.00 | -80.00 | -104.00 |
| EPS Diluted Continuous Ops | -57.02 | -92.03 | -81.95 | -79.19 | -104.10 |
| EBITDA(a) | $-1,995 | $-3,017 | $-2,696 | $-2,441 | $-3,258 |